IMV IMV Inc.

IMV Inc is a clinical-stage immuno-oncology company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:IMV.

$0.68  +0.02 (3.13%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  
IPO date:  10/09/2009
Outstanding shares:  82,269,462
Average volume:  83,936
Market cap:   $53,870,044
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      40-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   4.75
PS ratio:   0.00
Return on equity:   -343.08%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy